X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (198) 198
oncology (193) 193
index medicus (186) 186
female (154) 154
middle aged (135) 135
cancer (132) 132
aged (128) 128
male (121) 121
quality of life (105) 105
chemotherapy (99) 99
adult (82) 82
treatment outcome (70) 70
care and treatment (59) 59
hematology, oncology and palliative medicine (58) 58
antineoplastic combined chemotherapy protocols - therapeutic use (57) 57
survival (55) 55
life sciences (54) 54
aged, 80 and over (52) 52
clinical trials (52) 52
disease-free survival (49) 49
prognosis (49) 49
metastasis (45) 45
research (41) 41
analysis (39) 39
survival analysis (38) 38
surgery (36) 36
fluorouracil - administration & dosage (34) 34
clinical-trials (33) 33
breast cancer (32) 32
health-related quality of life (32) 32
surveys and questionnaires (32) 32
oxaliplatin (30) 30
therapy (30) 30
colorectal cancer (29) 29
france (29) 29
neoplasm staging (29) 29
fluorouracil (28) 28
patients (28) 28
prospective studies (28) 28
kaplan-meier estimate (27) 27
radiotherapy (27) 27
quality-of-life (26) 26
time factors (26) 26
retrospective studies (25) 25
pancreatic cancer (24) 24
chemotherapy, adjuvant (23) 23
combined modality therapy (23) 23
survival rate (23) 23
leucovorin - administration & dosage (22) 22
neoplasm metastasis (22) 22
adenocarcinoma (21) 21
cancer therapies (21) 21
cisplatin (21) 21
medicine & public health (21) 21
oncology, experimental (21) 21
patient outcomes (21) 21
proportional hazards models (21) 21
bevacizumab (20) 20
follow-up studies (20) 20
health aspects (20) 20
multivariate analysis (20) 20
questionnaires (20) 20
health care sciences & services (19) 19
breast neoplasms - pathology (18) 18
camptothecin - analogs & derivatives (18) 18
colorectal neoplasms - drug therapy (18) 18
european-organization (18) 18
methodology (18) 18
adenocarcinoma - drug therapy (17) 17
cancer patients (17) 17
carcinoma (17) 17
gastroenterology & hepatology (17) 17
gemcitabine (17) 17
organoplatinum compounds - administration & dosage (17) 17
trial (17) 17
[ sdv.can ] life sciences [q-bio]/cancer (16) 16
antineoplastic combined chemotherapy protocols - administration & dosage (16) 16
chemoradiotherapy (16) 16
colorectal neoplasms - pathology (16) 16
deoxycytidine - analogs & derivatives (16) 16
disease progression (16) 16
leucovorin (16) 16
neoadjuvant therapy (16) 16
overall survival (16) 16
studies (16) 16
5-fluorouracil (15) 15
antineoplastic agents (15) 15
breast neoplasms - drug therapy (15) 15
camptothecin - administration & dosage (15) 15
health status (15) 15
humanities (15) 15
longitudinal studies (15) 15
neoplasms - therapy (15) 15
phase-iii trial (15) 15
randomized-trial (15) 15
research design (15) 15
study protocol (15) 15
validation (15) 15
young adult (15) 15
antineoplastic combined chemotherapy protocols - adverse effects (14) 14
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of Oncology, ISSN 0923-7534, 9/2008, Volume 19, Issue 9, pp. 1592 - 1599
Background: The role of chemoradiation with systemic chemotherapy compared with chemotherapy alone in locally advanced pancreatic cancer (LAPC) is uncertain.... 
5-fluorouracil | Gemcitabine | Pancreatic cancer | Maintenance | Overall survival | Chemoradiotherapy | Randomized phase III trial | Cisplatin | CONSOLIDATIVE CHEMORADIATION | ADENOCARCINOMA | chemoradiotherapy | INITIAL TREATMENT | RANDOMIZED-TRIAL | CHEMOTHERAPY | RADIATION-THERAPY | pancreatic cancer | COMBINED RADIOCHEMOTHERAPY | ONCOLOGY | randomized phase III trial | overall survival | gemcitabine | RADIOTHERAPY | cisplatin | maintenance | CONCURRENT CHEMORADIOTHERAPY | Immunohistochemistry | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Male | Cisplatin - administration & dosage | Dose-Response Relationship, Drug | Fluorouracil - administration & dosage | Fluorouracil - adverse effects | Neoplasm Invasiveness - pathology | Adult | Deoxycytidine - adverse effects | Female | Pancreatic Neoplasms - mortality | Chemotherapy, Adjuvant | Radiotherapy, Adjuvant | Radiotherapy Dosage | Drug Administration Schedule | Risk Assessment | Deoxycytidine - administration & dosage | Pancreatic Neoplasms - pathology | Probability | Treatment Outcome | Combined Modality Therapy | Remission Induction | Survival Analysis | Cisplatin - adverse effects | Aged | Biopsy, Needle | Infusions, Intravenous | Neoplasm Staging | Deoxycytidine - analogs & derivatives | Pancreatic Neoplasms - therapy | Index Medicus
Journal Article
Journal Article
by Aparicio, Thomas and Ducreux, Michel and Faroux, Roger and Barbier, Emilie and Manfredi, Sylvain and Lecomte, Thierry and Etienne, Pierre-Luc and Bedenne, Laurent and Bennouna, Jaafar and Phelip, Jean-Marc and François, Eric and Michel, Pierre and Legoux, Jean-Louis and Gasmi, Mohamed and Breysacher, Gilles and Rougier, Philippe and De Gramont, Aimery and Lepage, Come and Bouché, Olivier and Seitz, Jean-François and Adenis, A and Alessio, A and Aouakli, A and Azzedine, A and Bedjaoui, A and Bidault, A and Blanchi, A and Botton, A and Cadier-Lagnes, A and Fatisse, A and Gagnaire, A and Gilbert, A and Gueye, A and Hollebecque, A and Lemaire, A and Mahamat, A and Marre, A and Patenotte, A and Rotenberg, A and Roussel, A and Thirot-Bidault, A and Votte, A and Weber, A and Zaanan, A and Dupont-Gossart, A.C and Villing, A.L and Queuniet, A.M and Coudert, B and Denis, B and Garcia, B and Lafforgue, B and Landi, B and Leduc, B and Linot, B and Paillot, B and Rhein, B and Winkfield, B and Barberis, C and Becht, C and Belletier, C and Berger, C and Bineau, C and Borel, C and Brezault, C and Buffet, C and Cornila, C and Couffon, C and De La Fouchardière, C and Giraud, C and Lecaille, C and Lepere, C and Lobry, C and Locher, C and Lombard-Bohas, C and Paoletti, C and Platini, C and Rebischung, C and Sarda, C and Vilain, C and Briac-Levaché, C and Auby, D and Baudet-Klepping, D and Bechade, D and Besson, D and Cleau, D and Festin, D and Gargot, D and Genet, D and Goldfain, D and Luet, D and Malka, D and Peré-Vergé, D and Pillon, D and Sevin-Robiche, D and Smith, D and Soubrane, D and Tougeron, D and Zylberait, D and Carola, E and Cuillerier, E and ... and FFCD Investigators and for FFCD investigators
European Journal of Cancer, ISSN 0959-8049, 07/2018, Volume 98, pp. 1 - 9
Journal Article
Annals of Oncology, ISSN 0923-7534, 09/2012, Volume 23, Issue suppl 9, pp. ix462 - ix468
Journal Article
by Mok, T. S. K and Paz-Ares, L and Wu, Y.-L and Novello, S and Juhasz, E and Aren, O and Sun, Y and Hirsh, V and Smit, E. F and Lathia, C and Ong, T. J and Pena, C and Pivot, X and Romieu, G and Bonnefoi, H and Pierga, J.-Y and Kerbrat, P and Guastalla, J.-P and Lortholary, A and Espie, M and Fumoleau, P and Serin, D and Jacquin, J.-P and Jouannaud, C and Rios, M and Abadie-Lacourtoisie, S and Tubiana-Mathieu, N and Cany, L and Catala, S and Khayat, D and Pauporte, I and Kramar, A and Goldhirsch, A and Piccart, M and Procter, M and De Azambuja, E and Weber, H and Untch, M and Smith, I. E and Gianni, L and Jackisch, C and Cameron, D and Bell, R and Dowsett, M and Gelber, R. D and Leyland-Jones, B and Baselga, J and Baum, M and Vaidya, J. S and Bulsara, M. K and Wenz, F and Tobias, J. S and Eiermann, W and Joseph, D and Pierga, J and Asselain, B and Alsafadi, S and Brain, E and Lerebours, F and Delaloge, S and Gentien, D and Servant, N and Sigal-Zafrani, B and Andre, F and Criscitiello, C and Azim, H. A and Agbor-Tarh, D and Eidtmann, H and Di Cosimo, S and Bradbury, I and Rubio, I. T and Semiglazov, V and Zurawski, B and Allerton, R and Fabi, A and Ciruelos, E and Parikh, R and DeSilvio, M and Santillana, S and Swaby, R and Verma, S and Miles, D and Krop, I and Welslau, M and Pegram, M and Oh, D and Dieras, V and Guardino, E and Fang, L and Lu, M. W and Olsen, S and Blackwell, K and Bachelot, T and Campone, M and Ballester, M. A and Commo, F and Goncalves, A and Levy, C and Ferrero, J and Lacroix, L and ... and on behalf of the TARGIT trialists group
Annals of Oncology, ISSN 0923-7534, 09/2012, Volume 23, Issue suppl 9, pp. ixe1 - ixe30
Journal Article
by Fountzilas, G and Gogas, H and Pavlidis, N and Eleftheraki, A and Skarlos, D and Koutras, A and Timotheadou, E and Papandreou, C and Pectasides, D and Dimopoulos, M and Criscitiello, C and Azim, H. A and Agbor-Tarh, D and De Azambuja, E and Piccart, M and Baselga, J and Eidtmann, H and Di Cosimo, S and Bradbury, I and Rubio, I. T and Fedele, P and Nacci, A and Lapolla, A. M and Orlando, L and Schiavone, P and Marino, A and Cinefra, M and Ardizzone, A and De Pasquale, M and Cinieri, S and Hennessy, B and Faratian, D and Ju, Z and Lluch-Hernandez, A and Myhre, S and Gonzalez-Angulo, A. M and Overgaard, J and Alsner, J and Borresen-Dale, A and Mills, G. B and Ciruelos, E and De Velasco, G. A and Gamez, A and Castaneda, C and Sepulveda, J and Ghanem, I and Cortes-Funes, H and Fresno, J. A and Cusumano, P and Generali, D. G and Manso, L and Lifrange, E and Jerusalem, G and Klaase, J and Stork-Sloots, L and Holzik, M. L and Albanell, J and Holt, S and Gligorov, J and Eiermann, W and Svedman, C and Fernando, I. N and Bowden, S. J and Brookes, C and Brunt, A. M and Churn, M and Steven, J. H and Agrawal, R. K and Rea, D and Melichar, B and Stroyakovskiy, D and Ahn, J. S and Kopp, M. V and Srimuninnimit, V and Kunz, G and Li, J and van der Horst, T and Muehlbauer, S and Jackisch, C and Rothe, F and Aura, C. M and Bavington, M and Maetens, M and Rouas, G and Sotiriou, C and Ignatiadis, M and Elkhouly, E. A and Metwally, H. M and Hashem, T. A and Abdalaziz, K. K and Gucalp, A and Gupta, G and Patil, S and Wen, Y. H and Akram, M and Brogi, E and Powell, S and Ho, A and Hudis, C. A and Traina, T. A and ...
Annals of Oncology, ISSN 0923-7534, 09/2012, Volume 23, Issue suppl 9, pp. ix95 - ix115
Journal Article
by Borad, M and Reddy, S and Bahary, N and Uronis, H and Sigal, D. S and Cohn, A. L and Schelman, W and Stephenson, J and Eng, C and Ryan, D. P and Waddell, T. S and Reis-Filho, J and Gonzalez-De-Castro, D and Chau, I and Wotherspoon, A and Gupta, S and Saffery, C and Middleton, G and Wadsley, J and Cunningham, D and Ajani, J. A and Pantigoso, W. R and Bodoky, G and Moiseyenko, V and Lichinitser, M and Gorbunova, V. A and Vynnychenko, I and Lang, I and Falcon, S and Daniele, B and Rimassa, L and Porta, C and Borbath, I and Salvagni, S and van Laethem, J and van Vlierberghe, H and von Roemeling, R and Abbadessa, G and Santoro, A and Bronowicki, J and Ye, S and Kudo, M and Marrero, J and Venook, A and Nakajima, K and Lencioni, R and Iwase, H and Shimada, M and Tsuzuki, T and Ryuge, N and Kida, Y and Kato, B and Esaki, M and Tanaka, Y and Urata, N and Hamai, Y and Hihara, J and Emi, M and Aoki, Y and Okada, M and Ezoe, Y and Muto, M and Ueda, K and Ozaki, Y and Aoyama, I and Horimatsu, T and Morita, S and Miyamoto, S and Chiba, T and Xu, Y and Mao, W and Sun, X. J and Zheng, Y. D and Jiang, Y and Liu, J and Bria, E and De Manzoni, G and Beghelli, S and Tomezzoli, A and Barbi, S and Frizziero, M and Sperduti, I and Bersani, S and Tortora, G and Scarpa, A and Xia, J and Zhao, J and So, S and Pan, K and Wang, W and Li, X and Chen, J and Wang, D and Kurokawa, Y and Matsuura, N and Kimura, Y and Kawabata, R and Adachi, S and Fujita, J and Nishikawa, K and ... and on behalf of Phase 3 Principle Investigators
Annals of Oncology, ISSN 0923-7534, 09/2012, Volume 23, Issue suppl 9, pp. ix224 - ix257
Journal Article
BREAST, ISSN 0960-9776, 06/2017, Volume 33, pp. 203 - 203
Journal Article
Annals of Oncology, ISSN 0923-7534, 01/2016, Volume 27, Issue 1, pp. 121 - 127
Journal Article
Oncologie, ISSN 1292-3818, 1/2017, Volume 19, Issue 1, pp. 41 - 41
Journal Article
Journal Article
BMC Gastroenterology, ISSN 1471-230X, 08/2014, Volume 14, Issue 1, p. 143
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 12/2011, Volume 17, Issue 23, pp. 7470 - 7478
Purpose: Adding oxaliplatin to adjuvant 5-fluorouracil (5-FU) chemotherapy improves 3-year disease-free survival (DFS) after resection of stage III colon... 
5-FLUOROURACIL | LEUCOVORIN | IMPACT | LYMPH-NODE RATIO |